Toronto Immune and Digestive Health Institute

North YORK, Ontario M6A 3B4

1 studies enrolling now · 1 studies all time

What they study most

Moderately to Severely Active Crohns Disease

Studies at this site

• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now